The pathobiology of arrhythmogenic cardiomyopathy

Annual Review of Pathology: Mechanisms of Disease

Volumn 6, Issue , 2011, Pages 299-321

  Saffitz, Jeffrey E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ARVC; cell biomechanics; desmosomes; gap junctions; sudden death

Indexed keywords

ADIPOCYTE; ARTICLE; CLINICAL FEATURE; DESMOSOME; GAP JUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEART INJURY; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; INTRACELLULAR SIGNALING; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUDDEN DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; HUMANS; MYOCARDIUM;

EID: 79751520349     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011110-130151     Document Type: Article

References (75)

1. Richardson P, McKenna WJ, Bristow M, Maisch B, Mautner B, et al. 1996. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841-42 (Pubitemid 26074816)
2. Provides the first clinical description of ARVC.
3. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. 1988. Right ventricular cardiomyopathy and sudden death in young people. N. Eng. J. Med. 318:129-33 (Pubitemid 18035134)
4. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. 2006. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J. Am. Med. Assoc. 296:1593-601 (Pubitemid 44515020)
5. Peters S, Trummel M, Meyners W. 2004. Prevalence of right ventricular dysplasia/cardiomyopathy in a nonreferral hospital. Int. J. Cardiol. 97:499-501 (Pubitemid 39550701)
6. ChoY,ParkT,YangDH, Park HS,Chae J, et al. 2003. Arrhythmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans. Circ. J. 67:925-28 (Pubitemid 37370241)
7. Gemayel C, Pelliccia A, Thompson PD. 2001. Arrhythmogenic right ventricular cardiomyopathy. J. Am. Coll. Cardiol. 38:1773-81 (Pubitemid 33116543)
8. Corrado D, Basso C, Thiene G, McLenna WJ, Davies MJ, et al. 1997. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J. Am. Coll. Cardiol. 30:1512-20 (Pubitemid 27486470)
9. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. 2009. Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289-300
10. Mallat Z, Tedjui A, Fontaliran F, Frank R, Durigon M, Fontaine G. 1996. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N. Eng. J. Med. 335:1190-96 (Pubitemid 26339773)
11. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, et al. 1998. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am. J. Pathol. 152:479-84 (Pubitemid 28106394)
12. Thiene G, Corrado D, Nava A, Rossi L, Poletti A, et al. 1991. Right ventricular cardiomyopathy: Is there evidence of an inflammatory etiology? Eur. Heart J. 12:22-25
13. Bowles NE,Ni J,MarcusR,Towbin JA. 2002. The detection of cardiotropic viruses in themyocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 39:892-95 (Pubitemid 34185340)
14. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lungvist C, et al. 1994. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the Interntional Society and Federation of Cardiology. Br. Heart J. 71:215-18
15. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, et al. 2010. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D); proposed modification of the task force criteria. Circulation 121:1533-43
16. Nava A, Bauce B, Basso C, MuriagoM, Rampazzo A, et al. 2000. Clinical profile and long-term follow-up of 37 familes with arrhythmogenic right ventricular cardiomyopathy. J. Am. Coll. Cardiol. 36:2226-33
17. Sen-Chowdhry S, Lower MD, Sporton SC, McKenna WJ. 2004. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am. J. Med. 117:685-95 (Pubitemid 40288176)
18. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, et al. 2009. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N. Eng. J. Med. 360:1075-84
19. De Pasquale CG, HeddleWF. 2001. Left sided arrhythmogenic ventricular dysplasia in siblings. Heart 86:128-30 (Pubitemid 32983470)
20. Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, et al. 2005. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112:636-42 (Pubitemid 41099041)
21. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, et al. 2008. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. Coll. Cardiol. 52:2175-87
22. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. 2007. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115:1710-20 (Pubitemid 46648607)
23. Zhurinsky J, ShtutmanM,Ben Ze'evA. 2000. Plakoglobin andâ-catenin: protein interactions, regulation and biological roles. J. Cell Sci. 113:3127-39
24. Kotteke MD, Delva E, Kowalczyk AP. 2006. The desmosome: cell science lessons from human diseases. J. Cell Sci. 119:797-806
25. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, et al. 2000. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119-24 (Pubitemid 30364661)
26. Norgett EE, Hatselll SJ, Carvajal-Huerta L, Cabezas JC, Common J, et al. 2000. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet. 9:2761-66
27. Rapazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, et al. 2002. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71:1200-6 (Pubitemid 35305239)
28. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, et al. 2004. Mutations in the desmosomal protein plakophilin 2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36:1162-64 (Pubitemid 41288964)
29. Pilichou K, Nava A, Basso C, Beffagne G, Bauce B, et al. 2006. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113:1171-79
30. Syrris P, Ward D, Asimaki A, Sen-Chowdhry S, Ebrahim HY, et al. 2006. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 113:356-64 (Pubitemid 43803196)
31. Heuser A, Plovie ER, Ellinot PT, Grossmann KS, Shin JT, et al. 2006. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Human. Genet. 79:1081-88 (Pubitemid 44853479)
32. Asimaki A, Syrris P,Wichter T, Mathias P, Saffitz JE,McKenna WJ. 2007. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 81:964-73 (Pubitemid 47580249)
33. Zhurinsky J, Shtutman M, Ben Ze'ev A. 2000. Differential mechanisms of LEF/TCF family dependent transcriptional activation by â-catenin and plakoglobin. Mol. Cell. Biol. 20:4238-52 (Pubitemid 30346619)
34. Saffitz JE. 2006. Adhesion molecules: why they are important to the electrophysiologist. J. Cardiovasc. Electrophysiol. 17:225-29 (Pubitemid 43344879)
35. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, at al. 2006. Suppression of canonical Wnt/â-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J. Clin. Investig. 116:2012-21 (Pubitemid 44033325)
36. LombardiR,Dong J, RodriguezG, Bell A, Leung TK, et al. 2009. Genetic fatemapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ. Res. 104:1076-84
37. Lombardi R, Marian AJ. 2010. Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells. Curr. Opin. Cardiol. 25:222-28
38. Protonotarios N, Tsatsopoulou A. 2004. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc. Pathol. 13:185-94 (Pubitemid 38798357)
39. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, et al. 1986. Cardiac abnormalities in familial palmoplantar keratosis. Br. Heart J. 56:321-26 (Pubitemid 16025012)
40. Carvajal-Huerta L. 1998. Epidermolytic-palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J. Am. Acad. Dermatol. 39:418-21 (Pubitemid 28417376)
41. Kaplan SR, Gard JJ, Carvajal-Huerta L, Ruiz-Cabezas JC, Thiene G, Saffitz JE. 2004. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc. Pathol. 13:26-32 (Pubitemid 38169463)
42. Sen-Chowdhry S, Syrris P, McKenna WJ. 2007. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 50:1813-21 (Pubitemid 350007965)
43. Awad MM, Calkins H, Judge DP. 2008. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5:258-67 (Pubitemid 351593909)
44. van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, et al. 2006. Plakophilin-2 mutations are the major determinant of arrhythmogenic right ventricular cardiomyopathy. Circulation 113:1650-58
45. Beffagne G, Occhi G, Nava A, Vitello L, Ditadi A, et al. 2005. Regulatory mutations in transforming growth factor â3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res. 65:366-73 (Pubitemid 40082478)
46. Tiso N, Stephan DA, Nava A, Bagattin A,Devaney JM, et al. 2001. Identification ofmutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD 2). Hum. Mol. Genet. 10:189-94 (Pubitemid 32123976)
47. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, et al. 2001. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196-200 (Pubitemid 32095402)
48. Merner ND, Hodgkinson KA, Haywood AF, Connors S, Frend VM, et al. 2008. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmogenic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet. 82:1-13
49. den Haan AD, Tan BT, Zikusoka MN, Llado LI, Jain R, et al. 2009. Comprehensive desmosome mutation analysis inNorth Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Cardiovasc. Genet. 2:428-35
50. Bhuiyan ZA, Jongbloed JD, van der Smagt J, Lombardi PM, Wiesfeld AC, et al. 2009. Desmoglein-2 and desmocollin-2 mutations in Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy patients: results from a multicenter study. Circ. Cardiovasc. Genet. 2:418-27
51. Bauce B, Nava A, Beffagna G, Basso C, Lorenzon A, et al. 2010. Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 7:22-29
52. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagne G, et al. 2009. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J. Am. Coll. Cardiol. 55:587-97
53. van Tintelen JP, van Gelder IC, Asimaki A, Suurmeijer AJH,Wiesfeld ACP, et al. 2009. Severe cardiac phenotypes with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm 6:1574-83
54. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, et al. 2004. Remodeling of gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1:3-11 (Pubitemid 38647241)
55. Tandri H, Asimaki A, Dalal D, Saffitz JE, Halushka M, Calkins H. 2008. Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation. J. Cardiovasc. Eletrophysiol. 19:1212-14
56. Saffitz JE. 2005. Dependence of electrical coupling on mechanical coupling in cardiac myocytes- insights gained from cardiomyopathies caused by defects in cell-cell communication. Ann. N.Y. Acad. Sci. 1047:336-44 (Pubitemid 41123852)
57. Kostin S, Hein S, Bauer EP, Schaper J. 1999. Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ. Res. 85:154-67 (Pubitemid 29343314)
58. Saffitz JE, Green KG, Kraft WJ, Schechtman KB, Yamada KA. 2000. Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium. Am. J. Physiol. Heart Circ. Physiol. 278:1662-70
59. Gutstein DE, Lie FY,Meyers MB, Choo A, Fishman GI. 2003. The organization of adherens junctions and desmosomes at the cardiac intercalated disk is independent of gap junctions. J. Cell Sci. 116:875-85 (Pubitemid 36367637)
60. Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, et al. 2005. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ. Res. 97:474-81 (Pubitemid 41298178)
61. Peters NS,Green CR, Poole-Wilson PA, SeversNJ. 1993. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88:864-75 (Pubitemid 23264001)
62. Nattel S, Maguy A, Le Bouter S, Yeh YH. 2007. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev. 87:425-56 (Pubitemid 47084677)
63. .63. Oxford EM, Musa H, Maass K, Coombs W, Taffet SM, Delmar M. 2007. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ. Res. 101:703-11 (Pubitemid 47494101)
64. Gallicano GI, Kouklis P, Bauer C, Yin M, Vasioukhin V. 1998. Desmoplakin is required early in development for assembly of desmosomes and desmosomal linkage. J. Cell Biol. 143:2009-22 (Pubitemid 29022620)
65. Ruiz P, BrinkmannV,Ledermann B, BehrendM,Grund C, et al. 1996. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J. Cell Biol. 135:215-25 (Pubitemid 26337749)
66. Grossman KS, Grund C, Huelsken J, Behrend M, Erdmann B, et al. 2004. Requirement of plakophilin2 for heart morphogenesis and cardiac junction function. J. Cell Biol. 167:149-60 (Pubitemid 39363422)
67. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, et al. 2006. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114:1799-806 (Pubitemid 44673354)
68. Yang Z, Bowles NE, Scherer SE, TaylorMD, Kearney DL, et al. 2006. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res. 99:646-55 (Pubitemid 44401456)
69. Basso C, Fox PR, Meurs KM, Towbin JA, Spier AW, et al. 2004. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 109:1180-85 (Pubitemid 38332624)
70. Oxford EM, Everitt M, Coombs W, Fox PR, Kraus M, et al. 2007. Molecular composition of the intercalated disc in a spontaneous canine animal model of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Heart Rhythm 4:1196-205 (Pubitemid 47324122)
71. OyamaMA, Reiken S, Lehnart SE,Chittur SV, MeursKM, et al. 2008. Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs is associated with calstabin2 deficiency. J. Vet. Cardiol. 10:1-10
72. Fox PR, Maron BJ, Basso C, Lie SK, Thiene G. 2000. Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: a new animal model similar to the human disease. Circulation 102:1863-70
73. Simpson MA, Cook RW, Solanki P, Patton MA, Dennis JA, Crosby AH. 2009. A mutation in NFêB interacting protein 1 causes cardiomyopathy and woolly haircoat syndrome of Poll Hereford cattle. Anim. Genet. 40:42-46
74. YinT,Getsios S, Caldelari R, Kowalczyk AP, Muller EJ, et al. 2005. Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 102:5420-25 (Pubitemid 40530273)
75. Huang H, Asimaki A, Lo D, McKenna WJ, Saffitz JE. 2008. Disparate effects of different mutations in plakoglobin on cell mechanical behavior. Cell Motil. Cytoskel. 65:964-78